New York State Contract Reporter #2140115

Three-year administration of the NeuroCatalyst Commercialization Fund

Empire State Development is seeking a third-party administrator for its $45 million NeuroCatalyst Commercialization Fund, which supports commercialization of life-science innovations addressing neurodegenerative diseases. - Government buyer: Empire State Development (ESD), with the opportunity associated with its Contract Administration division and Life Science Initiative. - Requested service: A qualified firm to implement and administer the Fund over a three-year term, supporting multiple anticipated annual application cycles. - Key responsibilities: - Develop, host, distribute, receive, process, and manage applications; screen eligibility and support cloud-based application evaluation. - Conduct applicant and awardee outreach, information sessions, marketing, and communications. - Recruit and coordinate expert reviewers and mentors; manage review, scoring, and synthesis of reviewer feedback; provide an as-needed mentor program. - Provide commercialization assistance, coordinate Advisory Committee communications and meetings, and manage grantee information collection. - Develop and maintain the Fund website or web content, and provide deliverables and reporting. - Fund focus: New York life-science research and innovations for neurodegenerative diseases, supporting efforts from academic translation through venture financing. - Participation goals: 6% SDVOB, 15% MBE, and 15% WBE. - Notable requirements: Applicable information-security standards and requirements include ISO 27001, ISO 27005, ISO 27035, relevant New York State and federal cybersecurity requirements, and GDPR where applicable. - OEMs and named vendors: No OEMs, product vendors, or specific products are identified. No hardware, part numbers, or purchase quantities are requested. - Contract value: The $45 million figure is the Fund amount, not a stated value for the administrator contract; the contract value is not provided.

Description

Empire State Development intends to establish a $45 million NeuroCatalyst Commercialization Fund to accelerate development and commercialization of life science research and innovations addressing neurodegenerative diseases. The agency seeks a qualified third-party firm to help implement and administer the Fund. Services include managing application development, distribution, and processing; conducting information sessions and outreach; arranging an as-needed mentor program; identifying and managing expert reviewers and mentors; and supporting marketing, website content, and stakeholder communications. The contract term is three years.

View original listing